NIM
IONS icon

NuWave Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

NuWave Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,434
Closed -$127K – 330
2022
Q2 		$127K Buy
+3,434
New +$129K 0.17% 163
2022
Q1 		– Sell
-3,762
Closed -$114K – 323
2021
Q4 		$114K Buy
+3,762
New +$118K 0.13% 200
2021
Q3 		– Sell
-551
Closed -$22K – 362
2021
Q2 		$22K Buy
+551
New +$21.6K 0.02% 293
2020
Q4 		– Sell
-3,558
Closed -$169K – 428
2020
Q3 		$169K Buy
+3,558
New +$198K 0.26% 126

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NuWave Investment Management's IONS Position: Q3 2022 in Review

NuWave Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2022, closing a stake of 3,434 shares — an estimated $127K sold.

NuWave Investment Management first reported a position in IONS in Q3 2020 and held it in 4 quarters. The position peaked at $169K in Q3 2020. 350 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • NuWave Investment Management reported no remaining Ionis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • NuWave Investment Management sold 3,434 Ionis Pharmaceuticals shares in Q3 2022, an estimated $127K.
  • NuWave Investment Management first reported a position in Ionis Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • NuWave Investment Management's Ionis Pharmaceuticals position peaked at $169K in Q3 2020.
  • 350 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.